SAM
Sectoral Asset Management’s Rocket Pharmaceuticals RCKT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-44,383
| Closed | -$296K | – | 106 |
|
|
2025
Q1 | $296K | Buy |
44,383
+4,200
| +10% | +$28K | 0.23% | 62 |
|
|
2024
Q4 | $505K | Sell |
40,183
-3,200
| -7% | -$40.2K | 0.34% | 58 |
|
|
2024
Q3 | $801K | Buy |
43,383
+30,853
| +246% | +$570K | 0.47% | 54 |
|
|
2024
Q2 | $270K | Sell |
12,530
-2,280
| -15% | -$49.1K | 0.11% | 82 |
|
|
2024
Q1 | $399K | Buy |
14,810
+2,530
| +21% | +$68.2K | 0.16% | 79 |
|
|
2023
Q4 | $368K | Sell |
12,280
-214,750
| -95% | -$6.44M | 0.16% | 88 |
|
|
2023
Q3 | $4.65M | Buy |
227,030
+36,240
| +19% | +$743K | 0.91% | 47 |
|
|
2023
Q2 | $3.79M | Hold |
190,790
| – | – | 0.63% | 67 |
|
|
2023
Q1 | $3.27M | Hold |
190,790
| – | – | 0.63% | 67 |
|
|
2022
Q4 | $3.73M | Sell |
190,790
-80,000
| -30% | -$1.57M | 0.72% | 59 |
|
|
2022
Q3 | $4.32M | Hold |
270,790
| – | – | 0.85% | 53 |
|
|
2022
Q2 | $3.73M | Sell |
270,790
-33,185
| -11% | -$457K | 0.75% | 57 |
|
|
2022
Q1 | $4.82M | Sell |
303,975
-79,000
| -21% | -$1.25M | 0.86% | 48 |
|
|
2021
Q4 | $8.36M | Sell |
382,975
-123,110
| -24% | -$2.69M | 1.26% | 33 |
|
|
2021
Q3 | $15.1M | Buy |
506,085
+35,950
| +8% | +$1.07M | 1.26% | 23 |
|
|
2021
Q2 | $20.8M | Buy |
470,135
+22,250
| +5% | +$985K | 1.68% | 14 |
|
|
2021
Q1 | $19.9M | Buy |
447,885
+80,500
| +22% | +$3.57M | 1.51% | 23 |
|
|
2020
Q4 | $20.1M | Buy |
+367,385
| New | +$20.1M | 1.42% | 29 |
|
|
2018
Q3 | – | Sell |
-237,158
| Closed | -$4.66M | – | 172 |
|
|
2018
Q2 | $4.66M | Buy |
237,158
+21,000
| +10% | +$412K | 0.52% | 51 |
|
|
2018
Q1 | $4.05M | Buy |
+216,158
| New | +$4.05M | 0.44% | 58 |
|